Initiative to Propel Development of Sleep Disorder Treatment
The Sleep Data Collection Initiative aims to accelerate the development of treatments for central disorders of hypersomnolence.
Source: sleepreviewmag.com
Stay updated with breaking news from Sleep Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Sleep Data Collection Initiative aims to accelerate the development of treatments for central disorders of hypersomnolence.
Zevra Therapeutics, formerly KemPharm, has joined the Sleep Data Initiative, led by RARE-X and the Sleep Consortium, as a founding member.
The Hypersomnia Foundation recently announced the appointment of two new leaders within their organization.